Home > Share Market > Stocks > Dr reddys laboratories > Financial Statements > DRREDDY Key Financial Ratios

Dr reddys laboratories Financial Statements

Dr reddys laboratories Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 8.74 22.70 0.60 (8.80)
Op profit growth 56.70 5.07 (4.90) (31)
EBIT growth 52.10 34.90 (12) (45)
Net profit growth (3.70) 114 (27) (39)
Profitability ratios (%)        
OPM 20.30 14.10 16.50 17.40
EBIT margin 15.40 11 10 11.40
Net profit margin 10.20 11.60 6.63 9.10
RoCE 15.20 10.80 8.12 9.71
RoNW 2.94 3.60 1.91 2.60
RoA 2.53 2.84 1.35 1.94
Per share ratios ()        
EPS 117 122 55 75.80
Dividend per share 25 25 20 20
Cash EPS 43.50 51.90 (7.90) 16
Book value per share 1,061 939 758 740
Valuation ratios        
P/E 38.50 25.60 37.90 34.70
P/CEPS 104 60 (265) 164
P/B 4.26 3.32 2.75 3.56
EV/EBIDTA 18.40 17.40 15.70 18.20
Payout (%)        
Dividend payout -- -- 35 25.70
Tax payout (33) 7.67 (32) (19)
Liquidity ratios        
Debtor days 95.70 94.60 100 102
Inventory days 77.10 66.80 73.60 69.60
Creditor days (46) (40) (45) (40)
Leverage ratios        
Interest coverage (30) (20) (18) (26)
Net debt / equity 0.09 0.13 0.38 0.37
Net debt / op. profit 0.40 0.81 2.04 1.83
Cost breakup ()        
Material costs (32) (32) (28) (26)
Employee costs (19) (19) (23) (22)
Other costs (29) (35) (33) (35)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000